The proposed Ki67 colocalization (Ki67CL) score can stratify ER+/HER2− BC patients with high significance in terms of BC‐specific survival (p < 0.00001) and distant metastasis‐free survival (p = 0.0048). Here, ESR1 is linked to breast cancer.